Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma (Q38084154)

28 August 2017

title

Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma (English)

1 reference

28 August 2017

1 reference

4

Fadlo R Khuri

1 reference

28 August 2017

Jacquelyn S Carr

1

1 reference

28 August 2017

Syed F Zafar

series ordinal

2

1 reference

28 August 2017

Nabil Saba

series ordinal

3

1 reference

28 August 2017

Bassel F El-Rayes

series ordinal

5

1 reference

28 August 2017

publication date

1 June 2013

1 reference

Journal of gastrointestinal cancer

28 August 2017

published in

1 reference

28 August 2017

volume

44

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

143-151

1 reference

Time trends of gastroesophageal reflux disease: a systematic review

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Esophageal adenocarcinoma incidence: are we reaching the peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Cancers with increasing incidence trends in the United States: 1999 through 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Prevalence of Barrett's esophagus in the general population: an endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Meta analysis: Cancer risk in Barrett's oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Incidence of adenocarcinoma among patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Mortality rates in patients with Barrett's oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

High-grade dysplasia in Barrett's esophagus: surveillance or operation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Population attributable risks of esophageal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Food group intake and risk of subtypes of esophageal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Nutrient intakes and adenocarcinoma of the esophagus and distal stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Carbohydrate consumption and esophageal cancer:an ecological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Risk factors for esophageal cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Family history of cancer and risk of esophageal and gastric cancers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9480-Z

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

21 January 2018

1 reference

12 December 2020

[A population-based matched case-control study on the risk factors of gastric cardia cancer]

1 reference

12 December 2020

Barrett's esophagus: development of dysplasia and adenocarcinoma

1 reference

12 December 2020

Gastro-oesophageal reflux disease

1 reference

12 December 2020

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium

1 reference

12 December 2020

Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma

1 reference

12 December 2020

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.

1 reference

12 December 2020

Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States

1 reference

12 December 2020

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma

1 reference

12 December 2020

The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia

1 reference

12 December 2020

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery

1 reference

12 December 2020

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

1 reference

12 December 2020

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

1 reference

12 December 2020

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

1 reference

12 December 2020

p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression

1 reference

12 December 2020

Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus

1 reference

12 December 2020

Familial risk for esophageal cancer: an updated epidemiologic study from Sweden

1 reference

12 December 2020

Etiology of Barrett's metaplasia and esophageal adenocarcinoma.

1 reference

12 December 2020

Low-grade dysplasia in Barrett's esophagus

1 reference

12 December 2020

Barrett's Esophagus and Obesity: The Missing Part of the Puzzle

1 reference

12 December 2020

Risk stratification of Barrett's esophagus: updated prospective multivariate analysis

1 reference

12 December 2020

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

1 reference

12 December 2020

p53 and neoplastic progression in Barrett's esophagus

1 reference

12 December 2020

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

1 reference

12 December 2020

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

12 December 2020

Factors responsible for the increasing incidence of oesophageal adenocarcinoma

1 reference

12 December 2020

10.1007/S12029-013-9480-Z

Identifiers

DOI

1 reference

28 August 2017

1 reference